Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 225
Gene Symbol: ABCD2
ABCD2
0.030 Biomarker disease BEFREE Combining Diffusion-Weighted Imaging Patterns with ABCD2 Score Predicts Stroke Risk after Transient Ischemic Attack. 30514189 2018
Entrez Id: 225
Gene Symbol: ABCD2
ABCD2
0.030 Biomarker disease BEFREE Comparison of Stroke Prediction Accuracy of ABCD2 and ABCD3-I in Patients with Transient Ischemic Attack: A Meta-Analysis. 28647418 2017
Entrez Id: 225
Gene Symbol: ABCD2
ABCD2
0.030 Biomarker disease BEFREE In addition, copeptin improved the prognostic value of the ABCD2 (age, blood pressure, clinical features of transient ischemic attack, duration of symptoms and presence of diabetes mellitus) score for a recurrent cerebrovascular event in transient ischemic attack. 27904159 2017
Entrez Id: 5825
Gene Symbol: ABCD3
ABCD3
0.020 Biomarker disease BEFREE Initiation of the ABCD3-I algorithm for expediated evaluation of transient ischemic attack patients in an emergency department. 31230922 2019
Entrez Id: 5825
Gene Symbol: ABCD3
ABCD3
0.020 GeneticVariation disease BEFREE Comparison of Stroke Prediction Accuracy of ABCD2 and ABCD3-I in Patients with Transient Ischemic Attack: A Meta-Analysis. 28647418 2017
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.020 GeneticVariation disease BEFREE ACE I/D genotypes were measured in 5688 of 6105 individuals with previous stroke or transient ischemic attack who participated in the PROGRESS trial. 12925557 2003
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.020 Biomarker disease BEFREE We conducted analyses of the effects of ACE inhibitor therapy on pneumonia in 6,105 patients with a history of stroke or transient ischemic attack enrolled in a randomized trial conducted in Australasia, Europe, and Asia. 14990394 2004
Entrez Id: 134
Gene Symbol: ADORA1
ADORA1
0.300 Therapeutic disease CTD_human Decreased extracellular adenosine levels lead to loss of hypoxia-induced neuroprotection after repeated episodes of exposure to hypoxia. 23437309 2013
Entrez Id: 213
Gene Symbol: ALB
ALB
0.010 AlteredExpression disease BEFREE Albumin expression may therefore be associated with ischemia‑induced delayed neuronal death in the CA1 region following transient cerebral ischemia. 28586018 2017
Entrez Id: 348
Gene Symbol: APOE
APOE
0.020 GeneticVariation disease BEFREE ApoE alleles do not exert a major influence on the development of microbleeds, but apoE epsilon2 may be associated with development of moderate to severe white matter disease in transient ischemic attack and stroke patients. 17322072 2007
Entrez Id: 348
Gene Symbol: APOE
APOE
0.020 Biomarker disease BEFREE Stroke/transient ischemic attack history was associated with incident dementia (HR=2.6) as well as AD (HR=2.4) among non-apolipoprotein E ɛ4 carriers. 21575878 2011
Entrez Id: 361
Gene Symbol: AQP4
AQP4
0.010 Biomarker disease BEFREE Improved long-term outcome after transient cerebral ischemia in aquaporin-4 knockout mice. 26767580 2017
Entrez Id: 551
Gene Symbol: AVP
AVP
0.010 Biomarker disease BEFREE Copeptin seems to be a promising independent biomarker for predicting the functional outcome and all-cause mortality within 3 months or 1 year after acute ischemic stroke, and it could also be a powerful tool for early risk stratification for patients with transient ischemic attack. 27904159 2017
Entrez Id: 572
Gene Symbol: BAD
BAD
0.300 Biomarker disease CTD_human Overexpression of copper/zinc superoxide dismutase in transgenic mice protects against neuronal cell death after transient focal ischemia by blocking activation of the Bad cell death signaling pathway. 12629175 2003
Entrez Id: 27113
Gene Symbol: BBC3
BBC3
0.010 AlteredExpression disease BEFREE Furthermore, TUNEL-positive CA1 pyramidal neurons were found at 5 days after TCI with increased expression levels of Bax, PUMA, and activated caspase-3. 31506563 2019
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1
0.030 Biomarker disease BEFREE The IRIS trial (Insulin Resistance Intervention after Stroke) demonstrated that pioglitazone decreased the composite risk for fatal or nonfatal stroke and MI in patients with insulin resistance without diabetes mellitus, after a recent ischemic stroke or transient ischemic attack. 28246237 2017
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1
0.030 Biomarker disease BEFREE The IRIS trial (Insulin Resistance Intervention after Stroke) demonstrated that pioglitazone reduced the risk for a composite outcome of stroke or myocardial infarction among nondiabetic patients with insulin resistance and a recent stroke or transient ischemic attack. 29084736 2018
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1
0.030 Biomarker disease BEFREE Methods- IRIS was a randomized placebo-controlled trial of pioglitazone that enrolled patients with insulin resistance but without diabetes mellitus within 180 days of an ischemic stroke or transient ischemic attack. 30580725 2018
Entrez Id: 682
Gene Symbol: BSG
BSG
0.010 Biomarker disease BEFREE Study of Serum CD147 Level in Patients with Transient Ischemic Attack and CD147 Expression in Atherosclerotic Plaque. 30039437 2018
Entrez Id: 718
Gene Symbol: C3
C3
0.300 Biomarker disease CTD_human Complement component 3 inhibition by an antioxidant is neuroprotective after cerebral ischemia and reperfusion in mice. 23199288 2013
Entrez Id: 23705
Gene Symbol: CADM1
CADM1
0.010 AlteredExpression disease BEFREE These results suggest that long-term treadmill exercise improves memory impairment through the restoration of decreased SynCAM 1/2/3 expression in the hippocampus induced by transient cerebral ischemia in the aged gerbil. 29341891 2018
Entrez Id: 253559
Gene Symbol: CADM2
CADM2
0.010 AlteredExpression disease BEFREE In addition, SynCAM 1/2/3 and SynCAM 2 expression in the hippocampus was significantly decreased in the sedentary group after transient cerebral ischemia; however, SynCAM 1/2/3 expressionand and SynCAM 2 protein level was significantly increased in the ischemic group with exercise. 29341891 2018
Entrez Id: 793
Gene Symbol: CALB1
CALB1
0.010 Biomarker disease BEFREE These findings suggest that ischemic preconditioning can attenuate transient cerebral ischemia-caused damage to the pyramidal neurons in the hippocampal CA1 area through maintaining calbindin D28k immunoreactivity. 28761424 2017
Entrez Id: 842
Gene Symbol: CASP9
CASP9
0.300 Biomarker disease CTD_human Manganese Superoxide Dismutase Affects Cytochrome c Release and Caspase-9 Activation After Transient Focal Cerebral Ischemia in Mice. 11333366 2001
Entrez Id: 847
Gene Symbol: CAT
CAT
0.010 Biomarker disease BEFREE In the present study, gerbils were orally pre‑treated with CIL, and changes of antioxidant enzymes including superoxide dismutase (SOD) 1 and SOD2, catalase (CAT) and glutathione peroxidase (GPX) in the hippocampal CA1 region following 5 min of transient cerebral ischemia were investigated and the neuroprotective effect of CIL in the ischemic CA1 region was examined. 28534982 2017